Skip to main content
. 2023 Sep 25;18:125. doi: 10.1186/s13020-023-00822-9

Fig. 4.

Fig. 4

The main molecular mechanism of ginsenosides anti-breast cancer. Ginsenosides can treat breast cancer through various targets and multiple signaling pathways. Cell cycle arrest, cell apoptosis, EMT, and cell autophagy are the most common phenotypic changes after ginsenoside intervention in breast cancer cells, and these phenotypic changes can achieve the purpose of treating breast cancer